APOHIDE Accelagen Pty Ltd
Product name
APOHIDE
Sponsor
Accepted date
Jul-2024
Active ingredients
oxybutynin hydrochloride
Proposed indication
Treatment of primary palmar hyperhydrosis
Application type
C (new indication)
Publication date
Jul-2024